New

ConsilX

The AI engine Fit Assessment

Beta

The company provides technology platforms for decentralized clinical trials and lists Top-10 Pharma and other pharma-related organizations among its clients, demonstrating pharma-focused tech solutions across trial management, eConsent, patient engagement, direct data collection, telemedicine, LifeLedger, and blockchain-based data sharing.

Blurb

Clinical Trial Patient Management on BlockChain

HQ Location

Singapore (Singapore)

Founded

2017

Employees

1 - 10

Total funding raised

Not available

Funding Status

Seed, June 5, 2017

Consilx is an award winning technology platform provider for decentralized clinical trials. ConsilX is founded by senior executives with extensive experience in clinical drug development, service industries and academic research institutions. Our clients include Top-10 Pharma, Global CRO Consortium, mid-tier CROs, and Research organizations.



The digital platforms provided Consilx are:

a) Digital Consenting platform for site-based & remote consenting. We also have an eConsent-Lite.

b) Patient Engagement solutions including visits tracking, medications compliance, adverse event alerts, etc.

c) Direct Data Capture through eSource (for site-based & tele-visits), eDiaries, questionnaires, wearables, devices

d) Telemedicine - Online video and audio communication between site and patients and related workflows

e) LifeLedgerâ„¢ - Decentralized trial platform managing the entire conduct of a clinical trial

f) Blockchain-based Micro Platforms for data notarization, post-trial data access to patients for permissioned sharing, verified & automated data and documents exchange amongst clinical trial partners



Visit us at www.consilx.com or write to us at info@consilx.com for more information.